748 related articles for article (PubMed ID: 27472461)
21. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
22. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
24. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
25. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
[TBL] [Abstract][Full Text] [Related]
26. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
27. The PTPRZ1-MET/STAT3/ISG20 axis in glioma stem-like cells modulates tumor-associated macrophage polarization.
Wang Y; Suo J; Wang Z; Ran K; Tian Y; Han W; Liu Y; Peng X
Cell Signal; 2024 Aug; 120():111191. PubMed ID: 38685521
[TBL] [Abstract][Full Text] [Related]
28. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
29. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
Herrera-Rios D; Li G; Khan D; Tsiampali J; Nickel AC; Aretz P; Hewera M; Suwala AK; Jiang T; Steiger HJ; Kamp MA; Muhammad S; Hänggi D; Maciaczyk J; Zhang W; Kahlert UD
Sci Rep; 2020 Oct; 10(1):16218. PubMed ID: 33004830
[TBL] [Abstract][Full Text] [Related]
30. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
[TBL] [Abstract][Full Text] [Related]
31. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
Sareddy GR; Viswanadhapalli S; Surapaneni P; Suzuki T; Brenner A; Vadlamudi RK
Oncogene; 2017 Apr; 36(17):2423-2434. PubMed ID: 27893719
[TBL] [Abstract][Full Text] [Related]
32. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L
Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636
[TBL] [Abstract][Full Text] [Related]
33. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
34. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
[TBL] [Abstract][Full Text] [Related]
35. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
Cilibrasi C; Riva G; Romano G; Cadamuro M; Bazzoni R; Butta V; Paoletta L; Dalprà L; Strazzabosco M; Lavitrano M; Giovannoni R; Bentivegna A
PLoS One; 2017; 12(1):e0169854. PubMed ID: 28081224
[TBL] [Abstract][Full Text] [Related]
37. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
[TBL] [Abstract][Full Text] [Related]
38. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
39. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
40. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
